TY - JOUR
T1 - Polymorphism of SLC6A2 gene does not influence outcome of myocardial (123)I-mIBG scintigraphy in patients with chronic heart failure
AU - Verschure, Derk O.
AU - Baas, F.
AU - van Eck-Smit, Berthe L. F.
AU - Somsen, G. Aernout
AU - Verberne, Hein J.
PY - 2016
Y1 - 2016
N2 - The NET, encoded by SLC6A2, is responsible for presynaptic NE-reuptake. (123)I-mIBG is clinically used to evaluate cardiac sympathetic function. However, it is unknown if polymorphism of SLC6A2 influences cardiac sympathetic activity as assessed with (123)I-mIBG. Therefore we studied the influence of SLC6A2 SNPs on myocardial (123)I-mIBG parameters in CHF. Forty-nine adults with stable CHF (age 66.5 ± 8.1 years, LVEF 22.3 ± 6.4) were enrolled. Fifteen minutes (early) and 4 hours (late) after administration of (123)I-mIBG planar images were acquired. The H/M ratio was calculated from the manually drawn ROI over the left ventricle and a fixed mediastinal ROI. Fourteen exons of the SLC6A2 gene were analyzed from whole blood samples. We found 6 different SLC6A2 SNPs, although none were functional. LVEF was the only independent predictor for early (adjusted R (2) = 0.063, p = 0.045) and late H/M ratio (adjusted R (2) = 0.116, p = 0.010). NT-proBNP was the only independent predictor for (123)I-mIBG WO (adjusted R (2) = 0.074, p = 0.032). SLC6A2 SNPs were not associated with any myocardial (123)I-mIBG-derived parameter. In this specific CHF population polymorphism of SLC6A2 gene was not associated with any (123)I-mIBG derived parameters
AB - The NET, encoded by SLC6A2, is responsible for presynaptic NE-reuptake. (123)I-mIBG is clinically used to evaluate cardiac sympathetic function. However, it is unknown if polymorphism of SLC6A2 influences cardiac sympathetic activity as assessed with (123)I-mIBG. Therefore we studied the influence of SLC6A2 SNPs on myocardial (123)I-mIBG parameters in CHF. Forty-nine adults with stable CHF (age 66.5 ± 8.1 years, LVEF 22.3 ± 6.4) were enrolled. Fifteen minutes (early) and 4 hours (late) after administration of (123)I-mIBG planar images were acquired. The H/M ratio was calculated from the manually drawn ROI over the left ventricle and a fixed mediastinal ROI. Fourteen exons of the SLC6A2 gene were analyzed from whole blood samples. We found 6 different SLC6A2 SNPs, although none were functional. LVEF was the only independent predictor for early (adjusted R (2) = 0.063, p = 0.045) and late H/M ratio (adjusted R (2) = 0.116, p = 0.010). NT-proBNP was the only independent predictor for (123)I-mIBG WO (adjusted R (2) = 0.074, p = 0.032). SLC6A2 SNPs were not associated with any myocardial (123)I-mIBG-derived parameter. In this specific CHF population polymorphism of SLC6A2 gene was not associated with any (123)I-mIBG derived parameters
U2 - https://doi.org/10.1007/s12350-016-0722-x
DO - https://doi.org/10.1007/s12350-016-0722-x
M3 - Article
C2 - 27844334
SN - 1071-3581
VL - 25
SP - 900
EP - 906
JO - Journal of Nuclear Cardiology
JF - Journal of Nuclear Cardiology
IS - 3
ER -